Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | small conductance calcium activated potassium | 0.032 | 1 | 0.5 |
Onchocerca volvulus | 0.0305 | 0.9069 | 0.5 | |
Brugia malayi | hypothetical protein | 0.0305 | 0.9069 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.032 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.032 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0305 | 0.9069 | 0.9069 |
Schistosoma mansoni | calcium-activated potassium channel | 0.032 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 2 ug ml-1 | Minimum inhibitory concentration of the compound against methicillin-resistant Staphyloccocus epidermidis UC12084 | ChEMBL. | 16033280 |
MIC (functional) | = 4 ug ml-1 | Minimum inhibitory concentration of the compound against methicillin, ciprofloxacin, rifampin, imipenem-resistant Staphyloccocus aureus UC12673 | ChEMBL. | 16033280 |
MIC (functional) | = 4 ug ml-1 | Minimum inhibitory concentration of the compound against penicillin-susceptible Streptococcus pneumoniae UC9912 | ChEMBL. | 16033280 |
MIC (functional) | = 4 ug ml-1 | Minimum inhibitory concentration of the compound against Enterococcus faecalis UC9217 | ChEMBL. | 16033280 |
MIC (functional) | = 8 ug ml-1 | Minimum inhibitory concentration of the compound against methicillin-susceptible Staphyloccocus aureus UC9213 | ChEMBL. | 16033280 |
MIC (functional) | = 16 ug ml-1 | Minimum inhibitory concentration of the compound against ampicillin-reisitant Haemophilus influenzae UC30063 | ChEMBL. | 16033280 |
MIC (functional) | > 64 ug ml-1 | Minimum inhibitory concentration of the compound against Escherichia coli UC6674 | ChEMBL. | 16033280 |
MIC (functional) | > 64 ug ml-1 | Minimum inhibitory concentration of the compound against Escherichia coli UC6674 | ChEMBL. | 16033280 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.